Obinutuzumab activates Fc gamma RI more potently than other anti-CD20 antibodies in chronic lymphocytic leukemia (CLL)

Elias, S; Kahlon, S; Kotzur, R; Kaynan, N; Mandelboim, O

Elias, S (reprint author), Hadassah Hebrew Univ Med Ctr, Dept Hematol, IL-91120 Jerusalem, Israel.; Mandelboim, O (reprint author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Immunol & Canc Res, Lautenberg Ctr Gen & Tumor Immunol,IMRIC, POB 12272, IL-9

ONCOIMMUNOLOGY, 2018; 7 (6):

Abstract

Treatment with monoclonal antibodies has revolutionized clinical medicine, especially in the fields of cancer and immunology. One of the oldest antibo......

Full Text Link